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Stillbirths: still neglected?
5 years ago, The Lancet published a groundbreaking 
(and taboo-breaking) Series on stillbirths. Its powerful 
mix of advocacy and hard data attracted more media 
attention than perhaps any other Series, and made 
waves on numerous levels, from the individual to the 
intergovernmental. Working closely with countries and 
WHO, the Series authors fought to bring “out of the 
shadows” the unacceptable toll of intrapartum stillbirths 
in low-income countries, the addressable diﬀ erences in 
stillbirth rates between countries with advanced health 
systems, and the deplorable absence of such devastating 
events from global tracking eﬀ orts such as those of 
the UN, the Millennium Development Goals, and the 
Global Burden of Disease. The Series brought home the 
injustice of ignoring these missing 2·6 million annual 
deaths, which result from the very same causes as 
those that kill newborn babies and pregnant women—
ie, complications of childbirth, maternal infections, 
maternal disorders such as hypertension and diabetes, 
fetal growth restriction, and congenital abnormalities. 
Last week saw the publication of a follow-up Series that 
begins with a paper assessing progress and ﬁ nishes with a 
call to end preventable stillbirths by 2030. In this month’s 
issue of The Lancet Global Health, we publish a linked Article 
in which the Stillbirth Series authors update the landmark 
2011 paper that produced the estimate of 2·6 million 
deaths. In the updated Article, Hannah Blencowe and 
colleagues reﬁ ne their methods by including more 
datapoints (almost twice as many as in 2011) and applying 
more stringent inclusion and exclusion criteria. Modelling 
was done for missing datapoints, of which there were sadly 
still many—only 32% of countries in southeast Asia had 
national data available. The authors ﬁ nd that the global 
estimate for 2015 is also 2·6 million, but the uncertainty 
range is narrower (2·4–3·0 million vs 2·14–3·82 million 
for the previous estimate). They compare this with an 
estimate of 3·25 million for 2000, corresponding to a 
19·4% decrease (uncertainty range –1·8 to 36·9%) since 
that date. The slowest rate of decline was in sub-Saharan 
Africa and the fastest was in east Asia.
The dominant nation in east Asia, China, has seen 
dramatic reductions in infant and child mortality, 
particularly in the past 15 years. Yet at the time of the 
previous Series estimates in 2011, no national data on 
stillbirths were available. To make up for this shortcoming, 
Jun Zhu and colleagues, who report their ﬁ ndings in a 
further Article published in this month’s issue, collected 
data on birth outcomes from 441 hospitals across China 
by means of the National Maternal Near Miss Surveillance 
System. This ambitious study found that, of the nearly 
4 million births in the studied hospitals between 2012 
and 2014, 37 855 were stillbirths at 28 weeks’ gestation 
or later, giving a stillbirth rate of 8·8 per 1000 births. 
Compared with Blencowe and colleagues’ global estimate 
of 18·4 per 1000 births for 2015, China comes out 
relatively well overall. The rate varied vastly by age and 
socioeconomic status, however, with strikingly high rates 
for women who were younger than 15 years, had not used 
antenatal care, were unmarried, or had no education.
Globally, monitoring and prioritisation eﬀ orts have 
seen some improvements since the previous Stillbirths 
Series. The adoption of the Every Newborn Action Plan 
at the WHO General Assembly in 2014 was a milestone 
in this regard. It calls for the stillbirth rate to be a core 
indicator of progress and sets a global target of 12 or 
fewer stillbirths per 1000 births by 2030. Furthermore, 
stillbirths are ﬁ rmly imbedded in the UN’s newly 
updated Global Strategy for Women, Children’s and 
Adolescents’ Health (2016–30), which, like The Lancet’s 
Series, includes the aim of ending preventable stillbirths 
by 2030. Nationally, however, progress has been 
uneven. For example, despite the Chinese Government’s 
admirable dedication to the reduction of maternal and 
neonatal mortality, its commitment to the issue of 
stillbirths is wanting. As Zhu and colleagues point out, 
“The annual number of stillbirths equals the annual 
number of neonatal deaths in China, yet stillbirths do not 
feature in the government’s 5 year plan for development 
of health or National Programme of Action for women 
and children. Most information systems do not include 
stillbirths, and data, where available, are not used”. The 
Chinese Government should take the publication of 
these data as a prompt to (1) incorporate standardised 
stillbirth measurement and monitoring into national 
strategic plans, and (2) “invest strategically in antenatal 
care, particularly for the most disadvantaged women, 
including the very young, unmarried, and illiterate”.
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